Carlyle Seeks New Investors For McDonald’s China Arm, US Judge Halts Several Johnson & Johnson’s Talc-Related Lawsuits, A Look At How Much Alphabet Analysts, Managers And Engineers Get Paid: Today’s Top Stories

Bloomberg Carlyle Seeks New Investors For McDonald’s $10B China Arm Private equity company Carlyle Group Inc (NASDAQ: CG) reportedly intends to find new investors for its investment in McDonald’s Corp’s (NYSE: MCD) Chinese operations. The buyout firm, which controls McDonald’s China, together with Trustar Capital, has been discussing shifting its ownership to a new investment vehicle. The report added that […]

Apple’s Upcoming AR/VR Headset Has Secret Tester ‘Blown Away’

Apple Inc.’s (NASDAQ:AAPL) upcoming mixed-reality headset has reportedly left a secret tester thoroughly impressed and “blown away” by its immersive capabilities.  What Happened: Evan Blass, a trustworthy leaker known for accurate predictions, such as regarding iPhone 12 mini, shared information about Apple’s highly anticipated mixed reality headset.  He said that a tester who has experienced multiple […]

Psyched Clinical Trials: Australian Univ. Pursues MDMA, MEAI Compound About To Set Off

Monash University Engages LaNeo MDMA Australian Monash University’s psychedelics research lab has contracted MDXX-class molecules developer PharmAla Biotech to manufacture and supply its clinical-grade MDMA LaNeo for an upcoming Phase 2 clinical study. Delivery is set for this summer. This is PharmAla’s fourth MDMA supply for a major clinical trial in Australia. Notably, PharmAla is […]

Is Starlink Going Public? Rumors Swirl As Elon Musk’s SpaceX Unit Eyes Profitability

Elon Musk‘s Starlink low-latency, satellite internet service has made serious inroads and proved its utility in times of calamities and other geopolitical tensions. Starlink, a unit of SpaceX, has long been rumored to consider an initial public offering, with the billionaire having weighed in on the possibility in the past. What Happened: Starlink could IPO […]

Elon Musk Hints At Suing OpenAI

In an interview with FOX News, Elon Musk talked about how he unfortunately helped create OpenAI. Talking about the dangers of Artificial Intelligence, Musk criticized OpenAI’s approach. After the interview, a … Full story available on Benzinga.com Read More

Why Catalent Shares Are Falling Today

Life-sciences company Danaher Corporation (NYSE: DHR) is reportedly no longer considering a takeover of contract manufacturer Catalent Inc (NYSE: CTLT) after expressing interest in buying the company earlier this year. While Danaher’s interest has cooled, it’s possible that Danaher could try and revive a deal conversation later, Bloomberg reported citing one of the people close to the matter. A deal between […]

Will iPhone 15 Launch Result In The Death Of These Old Models?

Are you eagerly anticipating the release of the iPhone 15? Well, brace yourself for some surprising news as Apple Inc. (NASDAQ:AAPL) may discontinue some of its most popular iPhone models after the upcoming Fall 2023 lineup launch.  What Happened: In September, later this year, Apple is expected to announce the iPhone 15 series. While it is too early to […]

AMC Shares Pop On Amazon Takeover Rumors: The Details

AMC Entertainment Holdings Inc (NYSE: AMC) shares are surging Tuesday afternoon following a report that Amazon.com Inc (NASDAQ: AMZN) is considering a buyout of the theater chain. What To Know: According to an Intersect report, Amazon founder and former CEO Jeff Bezos has told his investment advisors to look into a potential acquisition of AMC.  The report indicates […]

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Enveric Biosciences (NASDAQ: ENVB) has created an Australia-based subsidiary, Enveric Therapeutics, to support its next-generation psychedelics program for anxiety disorders. FSD Pharma Inc.’s (NASDAQ: HUGE) Australian business, FSD Pharma Australia, has been approved by the Alfred Ethics Committee to begin a Phase 1 clinical trial of […]